Ikena Oncology, Inc. financial data

Symbol
IKNA on Nasdaq
Location
50 Northern Ave., Boston, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Jul 24, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.34K % +0.81%
Debt-to-equity 10.8 % -18.7%
Return On Equity -24.9 % +41.9%
Return On Assets -22.5 % +37.9%
Operating Margin -823 % -81.4%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 48.3M shares 0%
Common Stock, Shares, Outstanding 48.3M shares 0%
Entity Public Float 51.3M USD -71.3%
Common Stock, Value, Issued 48K USD 0%
Weighted Average Number of Shares Outstanding, Basic 48.3M shares 0%
Weighted Average Number of Shares Outstanding, Diluted 48.3M shares 0%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 9.16M USD -41.4%
Research and Development Expense 19.1M USD -60.5%
General and Administrative Expense 22.4M USD -12.5%
Operating Income (Loss) -44.5M USD +41.1%
Nonoperating Income (Expense) 13.8M USD +59.3%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -30.6M USD +54.1%
Income Tax Expense (Benefit) 106K USD -75.8%
Net Income (Loss) Attributable to Parent -30.7M USD +53.9%
Earnings Per Share, Basic 0 USD/shares +53.9%
Earnings Per Share, Diluted 0 USD/shares +53.9%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 58.3M USD +31.7%
Marketable Securities, Current 37.4M USD -63.1%
Cash, Cash Equivalents, and Short-term Investments 176M USD +11.9%
Other Assets, Current 1.15M USD +19.3%
Assets, Current 99M USD -33.7%
Property, Plant and Equipment, Net 419K USD -45.7%
Operating Lease, Right-of-Use Asset 2.56M USD -46.4%
Assets 126M USD -19.9%
Accounts Payable, Current 512K USD -63.6%
Employee-related Liabilities, Current 483K USD -65.5%
Contract with Customer, Liability, Current 659K USD -94.6%
Liabilities, Current 7.32M USD -10.6%
Operating Lease, Liability, Noncurrent 1.84M USD -65.9%
Other Liabilities, Noncurrent 1.09M USD +5.71%
Liabilities 10.3M USD -29.9%
Accumulated Other Comprehensive Income (Loss), Net of Tax 65K USD
Retained Earnings (Accumulated Deficit) -343M USD -9.85%
Stockholders' Equity Attributable to Parent 116M USD -18.9%
Liabilities and Equity 126M USD -19.9%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -10.6M USD +42.3%
Net Cash Provided by (Used in) Investing Activities 7.93M USD
Common Stock, Shares Authorized 150M shares 0%
Common Stock, Shares, Issued 48.3M shares 0%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 59.2M USD +29.9%
Deferred Tax Assets, Valuation Allowance 112M USD +10.4%
Deferred Tax Assets, Gross 113M USD +9.21%
Operating Lease, Liability 7.52M USD -30%
Depreciation 87K USD -60.3%
Payments to Acquire Property, Plant, and Equipment 152K USD +361%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -30.3M USD +54.5%
Lessee, Operating Lease, Liability, to be Paid 8.1M USD -32.6%
Property, Plant and Equipment, Gross 2.04M USD -59.8%
Operating Lease, Liability, Current 3.83M USD +3.76%
Lessee, Operating Lease, Liability, to be Paid, Year Two 3.17M USD -24.7%
Lessee, Operating Lease, Liability, to be Paid, Year One 4.21M USD +7.34%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 582K USD -54.8%
Lessee, Operating Lease, Liability, to be Paid, Year Three 720K USD -77.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 1.01M USD +6.22%
Lessee, Operating Lease, Liability, to be Paid, Year Four 719K USD -12%
Additional Paid in Capital 459M USD +0.74%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 3.38M USD -52%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%